【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1.1 Betaferon/Betaseron/Extavia
04.1.2 Avonex/Rebif
04.1.3 Fampyra
04.1.4 Tecfidera
04.1.5 Tysabri
04.1.6 Gilenya
04.1.7 Copaxone
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Rate of Incidence and Prevalence
08. Market Segmentation by Molecule Type
08.1 Global Biologics Market
08.1.1 Market Size and Forecast
08.2 Global Small Molecules Market
08.2.1 Market Size and Forecast
09. Market Segmentation by Route of Administration
09.1 Global Oral Drugs Market
09.1.1 Market Size and Forecast
09.2 Global Parenteral Drugs Market
09.2.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Multiple Sclerosis Market in the US
10.1.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 Bayer
18.2.2 Biogen Idec
18.2.3 Merck Serono
18.2.4 Novartis
18.2.5 Teva Pharmaceuticals
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Bayer
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Strategy
19.1.5 Sales Segmentation by Business
19.1.6 Sales by Geographical Segmentation
19.1.7 Key Information
19.1.8 SWOT Analysis
19.2 Biogen Idec
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Geographical Segmentation by Revenue 2013
19.2.5 Business Strategy
19.2.6 Key Developments
19.2.7 SWOT Analysis
19.3 Merck Serono
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Geographical Segmentation by Revenue 2013
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Novartis
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Sales by Geography
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
19.5 Teva Pharmaceuticals
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation
19.5.4 Business Segmentation by Revenue 2013
19.5.5 Business Segmentation by Revenue 2012 and 2013
19.5.6 Sales by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Multiple Sclerosis Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type
Exhibit 4: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013
Exhibit 5: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2018
Exhibit 6: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013-2018 (US$ billion)
Exhibit 7: Global Multiple Sclerosis Drugs Market Segmentation by Molecule Type 2013-2018 (in percent)
Exhibit 8: Global Biologics Market 2013-2018 (US$ billion)
Exhibit 9: Global Small Molecules Market 2013-2018 (US$ billion)
Exhibit 10: Global Multiple Sclerosis Drugs Market by Route of Administration
Exhibit 11: Global Multiple Sclerosis Drugs Market by Route of Administration 2013
Exhibit 12: Global Multiple Sclerosis Drugs Market by Route of Administration 2018
Exhibit 13: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration 2013-2018 (US$ billion)
Exhibit 14: Global Multiple Sclerosis Drugs Market Segmentation by Route of Administration 2013-2018 (in percent)
Exhibit 15: Global Oral Drugs Market 2013-2018 (US$ billion)
Exhibit 16: Global Parenteral Drugs Market 2013-2018 (US$ billion)
Exhibit 17: Global Multiple Sclerosis Drugs Market by Geography 2013
Exhibit 18: Multiple Sclerosis Market in the US 2013-2018 (US$ billion)
Exhibit 19: Global Multiple Sclerosis Drugs Market by Vendor Segmentation 2013
Exhibit 20: Global Sales Comparison of Betaseron/Betaferon 2010-2013 (US$ million)
Exhibit 21: Sales of Avonex 2011-2013 (US$ million)
Exhibit 22: Sales of Tysabri 2011-2013 (US$ million)
Exhibit 23: Sales of Fampyra 2011-2013 (US$ million)
Exhibit 24: Sales Comparison of Avonex, Tysabri and Fampyra 2011-2013 (US$ million)
Exhibit 25: Sales of Rebif 2010-2013 (US$ million)
Exhibit 26: Sales of Rebif in North America 2010-2013 (US$ million)
Exhibit 27: Sales of Rebif in Europe 2010-2013 (US$ million)
Exhibit 28: Sales of Rebif in Emerging Markets and RoW 2010-2013 (US$ million)
Exhibit 29: Geography-wise Sales of Rebif 2010-2013 (US$ million)
Exhibit 30: Sales of Gilenya 2010-2013 (US$ million)
Exhibit 31: Sales of Extavia 2010-2013 (US$ million)
Exhibit 32: Sales of Gilenya and Extavia 2010-2013 (US$ million)
Exhibit 33: Quarter-wise Sales of Copaxone 2011-2013 (US$ million)
Exhibit 34: Quarter-wise Sales of Copaxone in the US 2011-2013 (US$ million)
Exhibit 35: Quarter-wise Sales of Copaxone Outside the US 2011-2013 (US$ million)
Exhibit 36: Business Segmentation of Bayer AG 2013
Exhibit 37: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
Exhibit 38: Sales Segmentation of Bayer AG by Geography 2013
Exhibit 39: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 40: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 41: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 42: Novartis AG: Business Segmentation by Revenue 2013
Exhibit 43: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 44: Novartis AG: Sales by Geography 2013
Exhibit 45: Teva Pharmaceutical Industries Ltd.: Business Segmentation
Exhibit 46: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2013
Exhibit 47: Teva Pharmaceutical Industries Ltd.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 48: Teva Pharmaceutical Industries Ltd.: Sales by Geography 2013
【レポート販売概要】
■ タイトル：世界の多発性硬化症治療薬市場（2014-2018）■ 英文：Global Multiple Sclerosis Drugs Market 2014-2018
■ 発行日：2014年8月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR3981
■ 調査対象地域：グローバル
- 使い捨て呼吸マスクの世界市場2019-2023107 Pages, November 2018 About this market Over the last few years, there has been a paradigm shift toward the adoption of disposable devices, especially in developed countries such as the UK and the US. Hospitals are taking precaution for any cross-contamination that could occur with reusable products. Governments in a few developed countries are encouraging the use of disposable surgical product …
- オンライン電子製品販売の世界市場2017-2021ABSTRACTAbout Online Electronics Retailing Electronic devices comprise electric circuits that include components such as transistors, integrated circuits, diodes, and interconnection technologies. Most electronic devices use semiconductors to perform electron controls. The global online electronics retailing market encompasses devices that are made of electronic components and are used in househol …
- 世界のウェアラブル電子機器市場と技術分析Wearable computers are small electronic devices worn by the user, which enable mobile computing and wireless networking. The term “Wearable technology” refers to any electronic device or product which can be worn by a person to integrate computing in his daily activity or work and use technology to avail advanced features & characteristics. Concerted efforts from industry and academia for over two …
- Ultra Petroleum Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 世界のヘテロジニアスネットワーク市場動向：Global Heterogeneous Networks Market 2014-2018TechNavio's analysts forecast the Global Heterogeneous Network market to grow at a CAGR of 27.9 percent over the period 2014-2018. One of the key factors contributing to this market growth is the inexorable demand for mobile broadband. The Global Heterogeneous Network market has also been witnessing the emergence of Wi-Fi-enabled small cells. However, the interference issues could pose a challenge …
- 工業用触媒の世界市場：石油精製、化学合成、石油化学・ポリマー用途About the Industrial Catalysts Market Catalysts accelerate a chemical reaction by providing an alternative route with lower activation energy. This results in a higher reaction rate for the same reactant concentrations and at the given temperature compared with uncatalyzed reactions. Industrial catalysts are used extensively in industrial processes, including petroleum refining, chemical synthesis …
- 人工心臓の世界市場分析：製品別（左、右、両腕補助装置）、セグメント予測The global ventricular assist device market is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology. Furthermore, increasing health …
- MES（製造実行システム）の世界市場2015-2019About MES MES acts as a means of communication between various divisions and helps in decision making by providing enterprise-wide records. The manufacturing industry uses MES automation software to improve operational performance by automating, executing, and managing manufacturing operations, such as scheduling, tracking, resource allocation and control, plant maintenance, labor planning, data a …
- ナノ印刷技術装置の世界市場2016-2020About the Global Nanolithography Equipment Market Nanolithography is the art and science of using lithographic techniques — like photolithography, nanoimprint lithography, X-ray lithography, and extreme ultraviolet (EUV) lithography — to produce nanostructures and devices. Nanolithography equipment is used to print complex nanometer-scale circuit patterns onto silicon wafers. This printing process …
- 機能性非肉系成分の世界市場：酸味料、抗菌剤、抗酸化成分、バインダー、着色料、酵素、エキステンダー＆フィラ－、香味料、防腐剤According to Stratistics MRC, the global functional non-meat ingredients market accounted for $28.2 billion in 2015 and is expected to grow at a CAGR of 4.59% to reach $38.62 billion by 2022. Rising demand for processed meat, rapidly growing food processing industry in emerging regions and increasing consumption of convenience foods are the factors driving the market growth. Outbreaks of livestock …
- 世界の特殊食品成分市場動向（～2018）The specialty food ingredients market is experiencing new traction due to rise in the demand for healthier & tasty food and changing lifestyles of the consumers. This report estimates the market value of specialty ingredients by types and applications. In terms of geography, the report is segmented into Asia-Pacific, Europe, North America, and Rest of the World (ROW). The specialty food ingredient …
- フタル酸ジオクチル(DOP)の世界市場予測Dioctyl Phthalate (DOP) 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about Dioctyl Phthalate (DOP) market in the all-in-one report issued in a logical and easily accessible format. In addition …
- プラスチック酸化防止剤の世界市場予測（～2024年）“Replacement of conventional materials by plastics in various industries is expected to drive the plastic antioxidants market.”The global plastic antioxidants market size is estimated to be USD 2.2 billion in 2019 and is projected to reach USD 2.8 billion by 2024, at a CAGR of 5.0%. The plastic antioxidants industry is driven largely by the increasing use of plastics in the packaging, building & c …
- 脊髄外傷治療用デバイスの世界市場ABSTRACTAbout Spinal Trauma Devices Spinal trauma refers to a severe injury to the spinal cord. It can occur due to accidents, falls, violence like a gunshot, or infections and requires the fixation of spinal trauma devices to treat bone deformities, facilitate bone fusion, strengthen and stabilize the spinal cord, and prevent further damage and complications. Technavio’s analysts forecast the glo …
- 産業用ファブリックの世界市場予測（～2023年）：ポリアミド、ポリエステル、アラミド、複合材料The market size of industrial fabric is estimated at USD 120.94 billion in 2018 and is projected to reach USD 153.60 billion by 2023, at a CAGR of 4.9% between 2018 and 2023. The growth of the market can be attributed to the increasing use of industrial fabrics in the automotive industry owing to the superior properties offered by these fabrics, such as high strength, rigidity, and heat resistance …
